Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IMRN stock hub

Immuron Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IMRNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IMRN

In the news

Latest news · IMRN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-39.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-25.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IMRN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

AUD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001660046
Company name	Immuron Limited
Country	Australia
Country code	US
Cusip	45254U101
Employees	7
Employees Change	1%
Employees Change Percent	16.67
Enterprise value	$-230,598
Exchange	NASDAQ
Financial currency	AUD
First seen	2026-05-09
Industry	Biotechnology
Isin	US45254U1016
Last refreshed	2026-05-10
Market cap	$6.9M
Market cap category	Nano-Cap
Price	$0.8
Price currency	USD
Rev Per Employee	712,477x
Sector	Healthcare
Sic	2834
Symbol	IMRN
Website	https://www.immuron.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-45.18%
FCF yield	-49.7%
P/B ratio	0.79x
P/S ratio	1.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-64.08%
EBITDA Margin	-63.39%
Gross margin	63.69%
Gross Profit	$3.2M
Gross Profit Growth	7.89%
Gross Profit Growth Q	67.92%
Gross Profit Growth3 Y	67.77%
Gross Profit Growth5 Y	56.02%
Net Income	$-3.1M
Net Income Growth Years	1%
Pretax Margin	-62.14%
Profit Margin	-62.14%
Profit Per Employee	$-442,735
ROA	-21.93
Roa5y	-17.99
ROCE	-36.07
ROE	-39.68
Roe5y	-35.12
ROIC	-25.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-56.75%
Cagr3y	-24.49%
Cagr5y	-31.25%
EPS Growth Years	1
Revenue Growth	14.3x
Revenue Growth Q	4.76x
Revenue Growth Years	4x
Revenue Growth3 Y	88.41x
Revenue Growth5 Y	50.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.55
Assets	$10.1M
Cash	$6.7M
Current Assets	$10.8M
Current Liabilities	$1.3M
Debt	$136,015
Debt Equity	$0.02
Equity	$8.7M
Interest Coverage	-485.5
Liabilities	$1.4M
Long Term Assets	$-724,652
Long Term Liabilities	$29,332
Net Cash	$6.5M
Net Cash By Market Cap	$95.21
Net Cash Growth	-39.74%
Net Debt Equity	$-0.75
Tangible Book Value	$8.7M
Tangible Book Value Per Share	$0.03
WACC	6.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.04
Inventory Turnover	1.44
Net Working Capital	$2.1M
Quick ratio	6.75
Working Capital	$8.7M
Working Capital Turnover	$0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.16%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-56.73%
200-day SMA	1.33
3Y total return	-56.96%
50-day SMA	0.81
50-day SMA vs 200-day SMA	50under200
5Y total return	-84.64%
All Time High	28.99
All Time High Change	-97.22%
All Time High Date	2020-06-09
All Time Low	0.68
All Time Low Change	18.98%
All Time Low Date	2025-12-30
ATR	0.07
Beta	0.41
Ch YTD	5.56
High	0.87
High52	2.39
High52 Date	2025-10-16
High52ch	-66.32%
Low	0.8
Low52	0.68
Low52 Date	2025-12-30
Low52ch	18.98%
Ma50ch	-0.37%
Price vs 200-day SMA	-39.25%
RSI	46.55
RSI Monthly	33.87
RSI Weekly	39.72
Sharpe ratio	-0.77x
Sortino ratio	-1
Total Return	-11.16%
Tr YTD	5.56
Tr1m	1.46%
Tr1w	1.63%
Tr3m	-0.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-3.2M
Operating margin	-64.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	320,652,888%
Float Percent	98.16%
Net Borrowing	-41,572.2
Shares Insiders	1.84%
Shares Institutions	43.26%
Shares Out	326,653,609
Shares Qo Q	17.43%
Shares Yo Y	11.16%
Short Float	0%
Short Ratio	0.58
Short Shares	0

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-3.6M
Average Volume	33,859.5x
Bv Per Share	0.03
CAPEX	$-3,170
Ch1m	1.46
Ch1w	1.63
Ch1y	-56.73
Ch3m	-0.11
Ch3y	-56.96
Ch5y	-84.64
Ch6m	-50.92
Change	-3.02%
Change From Open	-3.02
Close	0.83
Days Gap	0
Depreciation Amortization	37,372.4
Dollar Volume	2,042.8
Earnings Date	2026-02-25
Earnings Time	bmo
EBIT	$-3.2M
EBITDA	$-3.2M
EPS	$-0.01
F Score	2
FCF	$-3.4M
FCF EV Yield	1,478.38x
FCF Per Share	$-0.01
Financing CF	4,641,177
Fiscal Year End	June
Founded	1,994
Investing CF	107,693
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2025-09-25
Ma150	1.17
Ma150ch	-30.91%
Ma20	0.85
Ma20ch	-5.14%
Net CF	1,506,757
Next Earnings Date	2026-09-24
Open	0.83
Optionable	No
Position In Range	0
Post Close	0.8
Postmarket Change Percent	-0.61
Postmarket Price	$0.8
Ppne	154,503.6
Price Date	2026-05-08
Ptbv Ratio	0.79
Relative Volume	0.07x
Revenue	4,987,339x
SBC By Revenue	4.07x
Share Based Comp	202,937
Tr6m	-50.92%
Volume	2,538
Z Score	-2.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IMRN pay a dividend?

Capital-return profile for this ticker.

Performance

IMRN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IMRN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+43.3%

Float: +98.2% of shares outstanding

Insider ownership

+1.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IMRN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.6

Neutral momentum band

Price vs 200-day MA

-39.3%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

-0.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IMRN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IMRN stock rating?

Immuron Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IMRN analysis?

The full report lives at /stocks/IMRN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IMRN?

The latest report frames IMRN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IMRN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.